openPR Logo
Press release

Cardiac Biomarker Diagnostic Kits Market projected to grow at a CAGR of 5.2% from 2019 to 2027

09-15-2021 05:18 AM CET | Health & Medicine

Press release from: Transparancy Market Research

Cardiac Biomarker Diagnostic Kits Market

Cardiac Biomarker Diagnostic Kits Market

Transparency Market Research (TMR) has published a new report titled, ‘Cardiac Biomarker Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global cardiac biomarker diagnostic kits market was valued at around US$ 2.2 Bn in 2018 and is projected to grow at a CAGR of 5.2% from 2019 to 2027

 Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=62931

Overview

Cardiac biomarkers are also called cardiac markers. In a condition when the heart is damaged or stressed, cardiac biomarkers (endogenous substances including enzymes, hormones, and proteins) are released into the blood.
Generally, cardiac markers are used to diagnose heart attack and acute coronary syndrome (ACS) or conditions associated with insufficient blood flow to the heart. These markers are also utilized in the diagnosis and risk stratification of patients with chest pain.
Among cardiac biomarker tests, troponin is the biomarker test of choice for detecting heart damage. The test is performed with a blood sample using a needle to draw blood from a vein in the hand or arm. Troponin is elevated within a few hours of heart damage and stays elevated up to two weeks.
There are other established biomarkers, such as myoglobin (test used along with troponin for early detection of heart attack) and creatinine kinase isoenzymes (also called cardiac enzyme, which is linked with injury of heart muscle and detection of a second heart attack anticipated shortly after the first)

 Request for Analysis of COVID-19 Impact on Cardiac Biomarker Diagnostic Kits Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=62931

Rise in prevalence of cardiovascular diseases across the world to Drive Market

Growing prevalence of cardiovascular diseases across the world is the major driver for the growth of global cardiac biomarker diagnostic kits market.
For instance, the American Heart Association estimated that 121.5 million adults had cardiovascular diseases between 2013 and 2016
Advancements in novel technologies and increasing government funding for cardiovascular disease treatment are some of the major factors responsible for the growth of global cardiac biomarker diagnostic kits market
Moreover, early detection to track the heart condition and integration of cardiology & IT are also some of the major factors fuelling the growth of global cardiac biomarker diagnostic kits market

 Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=62931

Troponin Test Kits Segment to Dominate Market

Based on product, the global cardiac biomarker diagnostic kits market has been segmented into troponin test kits, CK-MB test kits, myoglobin test kits, BNP test kits, C-reactive Protein (hsCRP), and other biomarkers
Troponin test kits segment is accounted for major market share in global cardiac biomarker diagnostic kits market in 2018
Growth of troponin test kits segment can be ascribed to its prodigious specificity and ability to accurately detect the cardiac events of acute coronary syndrome (ACS).

 Buy  Cardiac Biomarker Diagnostic Kits Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=62931<ype=S

North America to Dominate Global Market

In terms of region, the global cardiac biomarker diagnostic kits market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America accounted for major share of the global cardiac biomarker diagnostic kits market in 2018 due to higher cardiovascular disease patient population, significant average selling price of analyzers, rise in demand for technologically advanced diagnostic instruments with enhanced specificity and precision among cardiologist, and favorable coverage as per the Clinical Laboratory Improvement Amendments for in-vitro diagnostic procedures in the region
For instance, an article published in the Medscape states that more than 9.8 million people in the U.S. experience symptoms of angina, annually, and more than 500,000 cases are registered every year
The cardiac biomarker diagnostic kits market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027. This can be ascribed to growing aging population, developing health care infrastructure, large patient population, increase in funding and investment toward the development of cardiac analyzers, and surge in focus of both international and domestic players in the region.

Competitive Landscape

The global cardiac biomarker diagnostic kits market is consolidated as few players hold major market share in global market. Key players include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthineers, bioMérieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., among other

Browse More Trending Reports by Transparency Market Research:      

Tranquilizer Drugs Market: https://www.transparencymarketresearch.com/tranquilizer-drugs-market.html

Congenital Adrenal Hyperplasia Market: https://www.transparencymarketresearch.com/congenital-adrenal-hyperplasia-market.html

Dental Infection Treatment Market: https://www.transparencymarketresearch.com/dental-infection-treatment-market.html

Contact

Mr. Rohit Bhisey
Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Biomarker Diagnostic Kits Market projected to grow at a CAGR of 5.2% from 2019 to 2027 here

News-ID: 2393174 • Views: 250

More Releases from Transparancy Market Research

Plasma Feed Market is projected to expand at a high CAGR from 2020 to 2030
Plasma Feed Market: Introduction According to the report, the global plasma feed market was valued at US$ 2.4 Bn in 2019 and is projected to expand at a high CAGR from 2020 to 2030. Plasma feed can be defined as feed products, which involve animal-derived plasma proteins and plasma as feed ingredients. Plasma, as an animal feed ingredient, is easily digestible and offers high quality protein. It primarily contains essential plasma proteins, including globulins and
Enteric Disease Testing Market set to witness surge in demand over the forecast …
The size of global enteric disease testing market has exhibited considerable promise for growth in the years to come. Favorable government policies and rapid technological progress are further promoting the growth of the global enteric disease testing market in years to come. In addition, the rising demand for early diagnosis is likely to emerge as another important factor for the market over the period of assessment. Meridian Bioscience, Biomerieux SA, CorisBioconcept SPRL, Alere
Hydroxychloroquine Drugs Market Size to Surge Vigorously during the Forecast Per …
Hydroxychloroquine Drugs Market – Scope of the Report TMR’s report on the global hydroxychloroquine drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global hydroxychloroquine drugs market for the period 2018–2030, considering 2019 as the base year and 2030 as the
Prosthetic Disc Nucleus Market Size will Grow Profitably in the Near Future
Prosthetic Disc Nucleus Market: Introduction According to the report, the global prosthetic disc nucleus market was valued at ~US$ 92 Mn in 2019. It is projected to expand at a moderate CAGR during the forecast period. Prosthetic disc nucleus is hydrogel-based spinal implant used as an adjunct treatment for patients with degenerative disc disorder and herniation, where surgical intervention is the only option. Prosthetic disc nucleus offers an alternative, cost-effective, and minimally invasive procedure to

All 5 Releases


More Releases for Cardiac

01-21-2021 | Health & Medicine
Fact.MR
Cardiac Ablation Technologies Market
Growing acceptance of catheter ablation as the first line of therapy, along with recent developments introducing robotic catheter navigation systems and 3D electro-anatomical mapping systems creates a highly conducive environment for the growth of the cardiac ablation technologies market. However, an extensive study published by Fact.MR raises concerns regarding technical complexity leading to lack of required operational competency, which leads to fundamental barriers to the adoption of advanced ablation systems. Request
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest. Browse 145 Market Data Tables and 119 Figures spread
Ambulatory Cardiac Monitoring Devices
Ambulatory Cardiac Monitoring Devices Market by Product (Ambulatory Rhythm Monitor, Ambulatory ECG Monitor, Ambulatory Cardiac Event Monitor, Implantable Loop Recorder, Ambulatory real-time Cardiac Monitors, Cardiac Output Monitors); by End-User (Hospitals, Ambulatory Care Centers); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) –
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Stupendous Growth …
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Mexico Cardiac Assist Devices
Mexico Cardiac Assist Devices Overview "Mexico Cardiac Assist Devices Market Outlook to 2025", provides key market data on the Mexico Cardiac Assist Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices. Click here for sample report @ https://www.wiseguyreports.com/sample-request/3107735-mexico-cardiac-assist-devices-market-outlook-to-2025   Major Key Players: Abbott Laboratories Medtronic plc Getinge AB. Major Highlight of the report: The report also provides
Cardiac Monitoring & Cardiac Rhythm Management Devices Market
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are